Invest in biomedical companies approved by specialists.
Become a shareholder in companies with high profitability and social impact.
INVEST WITH SPECIALISTS
All the investment rounds we publish have a specialised lead investor who has performed their own due diligence.
Total Amount Invested
HOW IT WORKS
At Capital Cell we only publish investment opportunities in biotechnology and life sciences companies that seek to improve people's quality of life.
Each company is thoroughly analyzed by the Capital Cell team, an independent network of experts called BioExpert Network, and our partners Alira Health, an international health and innovation consultancy.
Only 3% of the companies that approach Capital Cell end up being approved and published on the platform. We take uality very seriously!
Your participation, big or small, can affect the lives of millions of people. Minimum investments as low as 100€ ensure everyone can diversify their investment portfolio.
The BioExpert Network,the independent network of experts
Scientists, doctors, lawyers, experts in patents, regulatory affairs, finance or company valuation... This community of experts helps us filter the companies seeking funding. Thanks to their evaluations and feedback, we rule out 97% of the companies and only publish those with the best ratings.
are members of BioExpert Network
have been reviewed by our experts
Alira Healthhealth and innovation consulting
Alira Health is an international consultancy that provides a suite of integrated services designed to help companies in the healthcare and life sciences sector. Its market access and regulatory team evaluates each project and only those approved by the team are funded through Capital Cell.
Elion, industrial property agency
Elion is an industrial property (IP) agency, which helps biotech and medtech start-ups with their patent protection, writing and processing strategies, as well as freedom-to-operate studies. Its European patent agents assess the IP of companies that reach out to Capital Cell and only those with satisfactory protection and freedom-to-operate status are approved for funding.
"We have followed the evolution of Capital Cell since its inception in 2015. In this time it has established itself as the leading crowdfunding platform for life sciences companies. Daniel and his team have an excellent track record in selecting and promoting investment opportunities in the Spanish biotech sector. Thanks again, Daniel, for your advice and guidance that helped us successfully complete our recent investment round."
"Arjuna Therapeutics raised just under EUR1.5M on the Capital Cell platform in 2022. We were impressed by the whole Capital Cell team, who made the process seamless and painless. The BioExpert Network review was extremely useful, as we were reviewed by extremely knowledgeable individuals who asked intelligent questions and made some excellent suggestions. We’re delighted to be part of the Capital Cell community and we’re excited to see it expand throughout Europe as it addresses one of the key unmeet needs in biotech fundraising."
"The Capital Cell platform is a great tool to expand funding possibilities, reaching investors we would never have been able to reach without it. Daniel and the whole team have offered constant professional support throughout our campaign, helping us to become the first life sciences company in Spain to raise over €1M through equity crowdfunding; and then, on top of that, they took care of all the complicated legal paperwork!"
"I met Capital Cell while searching for a company posted on their platform. I was impressed both by their ability to select only companies with the best growth potential, as well as their ability to get the funding rounds they propose closed. When I heard that they were opening a round for themselves, I jumped at the chance. I am really happy to be part of this adventure."
"The BioExpert Network is a fundamental part of the service of Capital Cell. As members, we don't just evaluate projects that are shared in exchange for investment credit... We are fortunate to be among the first to get a glimpse of the new bio-revolution. It's a window into the future of applied life sciences - like a crystal ball to observe what will happen next in the healthcare sector!"
PARTNERS & COLLABORATORS
We and our investees collaborate with the best investment, science and social impact institutions so that you can invest in the best opportunities.
Looking for financing?
Each company is different so you will receive a personalized treatment. Share your pitch deck with us and you will receive a customized financing proposal, a report with detailed comments and recommendations that will help you raise the money you need.Share your pitch deck